1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with erbstatin in 5 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (erbstatin) | Trials (erbstatin) | Recent Studies (post-2010) (erbstatin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 145 | 0 | 2 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | erbstatin (IC50) |
---|---|---|---|
M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | 3.719 | |
Vif | Human immunodeficiency virus 1 | 1.72 | |
Tat | Human immunodeficiency virus 1 | 10.97 | |
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 2.4621 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 1.72 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demos, M; Duronio, V; Howard, SL; Hudson, AT; Jones, K; Pelech, SL; Reany, A; Salari, H | 1 |
Bonak, VA; Caon, AC; Gaudry, M; Gilbert, C; Huang, CK; McColl, SR; Naccache, PH; Umezawa, K | 1 |
Baldi, E; Bonaccorsi, L; Forti, G; Gervasi, G; Krausz, C; Luconi, M | 1 |
Edwards, SW; Watson, F | 1 |
El-Shazly, A; Eura, M; Ishikawa, T; Masuyama, K; Samejima, Y | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and erbstatin
Article | Year |
---|---|
Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets.
Topics: Animals; Antibodies; Blood Platelets; Enzyme Activation; Hydrolysis; Hydroquinones; In Vitro Techniques; Kinetics; Phosphatidylinositol Phosphates; Phosphatidylinositols; Phosphorylation; Phosphotyrosine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Protein-Tyrosine Kinases; Rabbits; Serotonin; Tyrosine | 1990 |
Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase.
Topics: Calcimycin; Chemotactic Factors; Humans; Hydroquinones; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphorylation; Platelet Activating Factor; Protein-Tyrosine Kinases; Superoxides; Tetradecanoylphorbol Acetate; Tyrosine | 1990 |
Stimulation of protein tyrosine phosphorylation by platelet-activating factor and progesterone in human spermatozoa.
Topics: Acrosome; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Genistein; Humans; Hydroquinones; Isoflavones; Male; Phosphorylation; Platelet Activating Factor; Progesterone; Protein-Tyrosine Kinases; Sperm Capacitation; Spermatozoa; Tyrosine | 1995 |
Stimulation of primed neutrophils by soluble immune complexes: priming leads to enhanced intracellular Ca2+ elevations, activation of phospholipase D, and activation of the NADPH oxidase.
Topics: Aniline Compounds; Antigen-Antibody Complex; Calcium; Enzyme Activation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroquinones; NADPH Oxidases; Neutrophils; Phospholipase D; Phosphorylation; Phosphotyrosine; Platelet Activating Factor; Protein-Tyrosine Kinases; Reactive Oxygen Species; Respiratory Burst; Signal Transduction; Vanadates; Xanthenes | 1998 |
Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate.
Topics: Benzoquinones; Chemokine CCL11; Chemokines, CC; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Cytokines; Enzyme Inhibitors; Eosinophils; Humans; Hydroquinones; In Vitro Techniques; Lactams, Macrocyclic; Platelet Activating Factor; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Quinones; Rifabutin; Vanadates; Vasoactive Intestinal Peptide | 1998 |